Stay updated on Omalizumab in CRSwNP: Extension Study Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.

Latest updates to the Omalizumab in CRSwNP: Extension Study Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page shows a new Revision: v3.3.4, replacing the previous Revision: v3.3.3. This appears to be a minor site revision and does not alter study content or functionality.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Study Locations section was updated with new sites across the US, Canada, Spain, and several European and former Soviet regions, and some previously listed locations were removed.SummaryDifference2%

- Check59 days agoChange DetectedAdded a note that PubMed publications are auto-filled from PubMed and updated the revision to v3.3.2, replacing the previous PubMed publication description and revision v3.2.0.SummaryDifference0.1%

- Check66 days agoChange DetectedThe government funding status notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check88 days agoChange DetectedThe page content and study details appear unchanged; only minor formatting and layout adjustments are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check109 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.SummaryDifference2%

Stay in the know with updates to Omalizumab in CRSwNP: Extension Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in CRSwNP: Extension Study Clinical Trial page.